Literature DB >> 20655942

Opioid mediation of starch and sugar preference in the rat.

Kristine B Bonacchi1, Karen Ackroff, Khalid Touzani, Richard J Bodnar, Anthony Sclafani.   

Abstract

In our prior studies, administration of the opioid receptor antagonist naltrexone did not block conditioned preferences for a flavor paired with a preferred sugar solution over a flavor paired with saccharin. This may be because both training solutions were sweet, and their attractiveness was reduced by naltrexone. The present study compared the effects of naltrexone on preferences for flavors paired with sugar or starch drinks that have distinctive tastes to rats. Experiment 1 assessed naltrexone's effect on the preference for unflavored 8% cornstarch and 8% sucrose aqueous solutions/suspensions. The food-restricted rats displayed a significant sucrose preference which increased following systemic treatment with naltrexone (1 or 3mg/kg) even though total intake of both solutions declined. In Experiment 2, rats were trained to drink flavored (cherry or grape) starch and sucrose solutions in separate one-bottle sessions. In a two-bottle choice test with both flavors presented in a sucrose-starch mixture, the rats significantly preferred the starch-paired flavor. Naltrexone treatment blocked the expression of this starch-conditioned preference. In Experiment 3, rats were treated with saline or naltrexone throughout one-bottle training with flavored sucrose and starch solutions. In a subsequent choice test, both the saline and naltrexone groups displayed significant preferences for the starch-paired flavor, indicating that opioid antagonism failed to alter the acquisition of this conditioned preference. In summary, novel outcomes of this study included the increased rather than the predicted decrease in sucrose preference produced by naltrexone. Also, starch unexpectedly conditioned the stronger flavor preference, although this can be explained by the differential post-oral reinforcing actions of starch and sucrose, and naltrexone blocked the expression, but not the acquisition, of this preference. These findings suggest that the reward value of starch in liquid form is more dependent upon opioid signaling than is that of sugar. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655942      PMCID: PMC2930144          DOI: 10.1016/j.pbb.2010.07.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  46 in total

1.  Flavor preferences conditioned by intragastric fructose and glucose: differences in reinforcement potency.

Authors:  K Ackroff; K Touzani; T K Peets; A Sclafani
Journal:  Physiol Behav       Date:  2001-04

Review 2.  Endogenous opioids and feeding behavior: a 30-year historical perspective.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2004-04       Impact factor: 3.750

3.  Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone.

Authors:  W Z Yu; A Sclafani; A R Delamater; R J Bodnar
Journal:  Pharmacol Biochem Behav       Date:  1999-11       Impact factor: 3.533

4.  Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions.

Authors:  A V Azzara; R J Bodnar; A R Delamater; A Sclafani
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

5.  Pain modulating and reward systems: a single brain mechanism?

Authors:  J Le Magnen; P Marfaing-Jallat; D Miceli; M Devos
Journal:  Pharmacol Biochem Behav       Date:  1980-05       Impact factor: 3.533

6.  Naltrexone infusion inhibits the development of preference for a high-sucrose diet.

Authors:  Allen S Levine; Martha K Grace; James P Cleary; Charles J Billington
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-11       Impact factor: 3.619

Review 7.  Neuropharmacology of learned flavor preferences.

Authors:  Khalid Touzani; Richard J Bodnar; Anthony Sclafani
Journal:  Pharmacol Biochem Behav       Date:  2010-06-19       Impact factor: 3.533

8.  Flavor enhances the antidipsogenic effect of naloxone.

Authors:  A S Levine; S S Murray; J Kneip; M Grace; J E Morley
Journal:  Physiol Behav       Date:  1982-01

9.  Naltrexone does not prevent acquisition or expression of flavor preferences conditioned by fructose in rats.

Authors:  Robert W Baker; Yin Li; Mariel G Lee; Anthony Sclafani; Richard J Bodnar
Journal:  Pharmacol Biochem Behav       Date:  2004-06       Impact factor: 3.533

Review 10.  Sugars: hedonic aspects, neuroregulation, and energy balance.

Authors:  Allen S Levine; Catherine M Kotz; Blake A Gosnell
Journal:  Am J Clin Nutr       Date:  2003-10       Impact factor: 7.045

View more
  5 in total

1.  The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.

Authors:  Matthew R Hayes; Scott E Kanoski; Bart C De Jonghe; Theresa M Leichner; Amber L Alhadeff; Samantha M Fortin; Myrtha Arnold; Wolfgang Langhans; Harvey J Grill
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-17       Impact factor: 3.619

Review 2.  Dopamine and learned food preferences.

Authors:  Anthony Sclafani; Khalid Touzani; Richard J Bodnar
Journal:  Physiol Behav       Date:  2011-05-01

Review 3.  Neural Basis of Dysregulation of Palatability-Driven Appetite in Autism.

Authors:  Anica Klockars; Tapasya Pal; Allen S Levine; Pawel K Olszewski
Journal:  Curr Nutr Rep       Date:  2021-08-21

4.  Glucose Intake Alters Expression of Neuropeptides Derived from Proopiomelanocortin in the Lateral Hypothalamus and the Nucleus Accumbens in Fructose Preference Rats.

Authors:  Guangfa Jiao; Guozhong Zhang; Haiying Wang; Weilin Zhao; Yanwei Cui; Yongjing Liu; Feng Gao; Fang Yuan; Yi Zhang
Journal:  Neural Plast       Date:  2017-11-08       Impact factor: 3.599

Review 5.  Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.

Authors:  Ewa Bojanowska; Joanna Ciosek
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.